Expert Perspectives on Managing Polyvascular Disease and Coronary Artery Disease

home / peer-exchange / expert-perspectives-on-managing-polyvascular-disease-and-coronary-artery-disease

A panel of experts discusses use of antithrombotic therapy for treatment of polyvascular disease, in particular coronary artery disease (CAD). They also share data in patients with CAD and peripheral artery disease (PAD) with dual pathway inhibition (DPI) and their insights on optimal duration of dual antiplatelet therapy (DAPT) and rationale for switching therapy.

© 2023 MJH Life Sciences

All rights reserved.